Advancing Regulatory Intelligence to Support Fundable Growth in MedTech…
MORRISVILLE, NC – March 3, 2026, MethodSense, Inc. a regulatory and quality advisory firm serving the medical device industry, today announced its sponsorship of the LSI USA ’26 Emerging Medtech Summit, taking place March 16–20, 2026 at the Waldorf Astoria Monarch Beach in Dana Point, California.
LSI USA brings together leading MedTech innovators, investors, and strategics to explore the forces shaping the future of medical technology, from capital formation and regulatory pathways to commercialization and execution discipline.
In today’s market, investors are asking harder questions. Regulatory timelines are scrutinized earlier. Quality system maturity is evaluated sooner. And milestone credibility increasingly determines which companies move forward and which are filtered out.
“LSI is where innovation meets capital,” said Rita King, CEO of MethodSense. “In this environment, regulatory credibility is no longer a back-office function. It is central to whether a company is viewed as fundable, scalable, and execution-ready.”
MethodSense works at the intersection of regulatory strategy and capital alignment. The firm helps:
- Founders turn regulatory plans into credible, fundable roadmaps
- Investors validate regulatory assumptions before and after capital deployment
- Companies approaching key inflection points strengthen execution discipline
- Boards restore alignment when regulatory milestones slip
At LSI USA ’26, MethodSense will highlight its expanded Capital & Investment Strategy advisory services, designed to align regulatory intelligence with capital decisions across the MedTech lifecycle.
The firm will also showcase LuminLogic, its compliance intelligence platform, which embeds regulatory discipline into daily operational workflows. LuminLogic supports change control, CAPA, risk management, traceability, audit readiness, and submission preparation, helping companies scale infrastructure early rather than reactively.
“When regulatory strategy, capital planning, and operational execution are aligned, companies move more predictably and capital moves with greater confidence,” King added. “That alignment is what today’s MedTech environment demands.”
MethodSense will be located at Booth 17 and is active on the official LSI event app.
To connect with the MethodSense team at LSI USA ’26, visit Booth 17, message the team through the LSI app, or visit Confident Growth Through Regulatory Intelligence | MethodSense.
About MethodSense
MethodSense, Inc. is a regulatory and quality consulting firm specializing in medical devices and life sciences. Through its consulting expertise and LuminLogic regulatory management platform, MethodSense helps companies navigate global regulatory pathways, manage documentation and submissions, and accelerate time to market for innovative healthcare technologies. Learn more at www.methodsense.com
###
Contact: Karl von Gunten, MethodSense, Inc
Email: kvongunten@methodsense.com
Website: https://methodsense.com/